Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-03 Sale |
2025-04-07 6:43 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
3,400,000 | $1.42 | $4,828,000 | 5,875,851 (Indirect) |
View |
| 2021-05-03 Purchase |
2024-10-21 8:22 pm |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
922 | $11.33 | $10,447 | 922 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:24 pm |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
16,041 | $4.7363 | $75,975 | 236,771 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:24 pm |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
10,834 | $4.7363 | $51,313 | 126,382 (Direct) |
View |
| 2024-03-12 Sale(A) |
2024-04-17 4:12 pm |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
11,537 | $3.164 | $36,503 | 252,812 (Direct) |
View |
| 2024-03-11 Sale(A) |
2024-04-17 4:10 pm |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
13,201 | $3.4064 | $44,968 | 130,154 (Direct) |
View |
| 2024-04-04 Purchase |
2024-04-08 5:32 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
177,993 | $4.6848 | $833,867 | 9,275,851 (Indirect) |
View |
| 2024-04-01 Purchase |
2024-04-03 5:22 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
504,272 | $3.8362 | $1,934,505 | 9,097,858 (Indirect) |
View |
| 2024-03-11 Sale |
2024-03-12 8:07 pm |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
13,201 | $3.4064 | $44,968 | 372,979 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 8:04 pm |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
29,768 | $3.3125 | $98,605 | 649,156 (Indirect Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 8:01 pm |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
183,238 | $3.1694 | $580,760 | 2,552,499 (Direct) |
View |
| 2023-10-16 Sale |
2023-10-18 5:15 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
2,756,499 | $1.6156 | $4,453,308 | 8,593,586 (Indirect) |
View |
| 2022-08-09 Purchase |
2022-08-11 4:08 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
115,000 | $7.5457 | $867,750 | 11,350,085 (Indirect) |
View |
| 2022-08-08 Purchase |
2022-08-10 4:10 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
97,000 | $7.24 | $702,280 | 11,235,085 (Indirect) |
View |
| 2022-08-05 Purchase |
2022-08-09 4:08 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
141,000 | $6.95 | $979,950 | 11,138,085 (Indirect) |
View |
| 2022-08-04 Purchase |
2022-08-08 4:09 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
95,100 | $6.17 | $586,767 | 10,997,085 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-17 Option Award |
2025-04-18 4:41 pm |
N/A 2035-04-16 |
Aldeyra Therapeutics Inc. | ALDX | Clark William D Director |
76,760 | $0 | 76,760 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:17 pm |
N/A 2035-03-03 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
809,710 | $0 | 809,710 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 4:13 pm |
N/A 2035-03-03 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
202,427 | $0 | 202,427 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:15 pm |
N/A 2034-06-03 |
Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director |
51,915 | $0 | 51,915 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:13 pm |
N/A 2034-06-03 |
Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director |
46,706 | $0 | 46,706 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:12 pm |
N/A 2034-06-03 |
Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director |
42,018 | $0 | 42,018 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:12 pm |
N/A 2034-06-03 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
42,018 | $0 | 42,018 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:12 pm |
N/A 2034-06-03 |
Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director |
45,664 | $0 | 45,664 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-06 4:06 pm |
N/A 2034-06-03 |
Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director |
46,359 | $0 | 46,359 (Direct) |
View |
| 2024-03-09 Option Award |
2024-03-12 8:07 pm |
N/A 2034-03-08 |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
252,280 | $0 | 372,979 (Direct) |
View |
| 2024-03-09 Option Award |
2024-03-12 8:04 pm |
N/A 2034-03-08 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
405,450 | $0 | 649,156 (Direct) |
View |
| 2024-03-09 Option Award |
2024-03-12 8:01 pm |
N/A 2034-03-08 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
1,081,201 | $0 | 2,552,499 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 5:42 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
273,058 | $0.552 | 1,654,536 (Direct) |
View |
| 2023-09-07 Tax Withholding |
2023-09-11 5:42 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
73,807 | $7.22 | 1,654,536 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 5:42 pm |
N/A 2023-09-07 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
273,058 | $0 | 1,654,536 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 4:31 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director |
5,437 | $0.552 | 14,812 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 4:31 pm |
N/A 2023-09-07 |
Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director |
5,437 | $0 | 14,812 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 4:13 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director |
9,604 | $0.552 | 15,854 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-24 4:13 pm |
N/A 2023-09-07 |
Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director |
9,604 | $0 | 15,854 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:46 pm |
N/A 2033-06-29 |
Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director |
24,606 | $0 | 24,606 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:43 pm |
N/A 2033-06-29 |
Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director |
24,423 | $0 | 24,423 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:42 pm |
N/A 2033-06-29 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
22,137 | $0 | 22,137 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:34 pm |
N/A 2033-06-29 |
Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director |
24,058 | $0 | 24,058 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:32 pm |
N/A 2033-06-29 |
Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director |
27,350 | $0 | 27,350 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 5:30 pm |
N/A 2033-06-29 |
Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director |
22,137 | $0 | 22,137 (Direct) |
View |
| 2023-06-27 Exercise |
2023-06-29 4:23 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director |
9,604 | $0.552 | 28,248 (Direct) |
View |
| 2023-06-27 Exercise |
2023-06-29 4:23 pm |
N/A 2023-09-07 |
Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director |
9,604 | $0 | 28,248 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:27 pm |
N/A 2033-02-27 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
220,258 | $0 | 220,258 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:25 pm |
N/A 2033-02-27 |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
110,028 | $0 | 110,028 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:22 pm |
N/A 2033-02-27 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
488,750 | $0 | 1,705,285 (Direct) |
View |